A number of subsequent studies have concluded that elevated levels of Apollon are linked to poor prognosis in a range of cancers, such as leukemia156,157, breast158, neuroblastoma159, prostate160–162, lung163, ovarian164, colorectal165, hepatocellular166, and head and neck167 cancers. Here, BIRC6 is linked to cancer.